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Small lymphocytes from  the  thoracic duct lymph of  rats  (1)  and mice  (2)  can 
initiate immune responses to  antigens such as  sheep  erythrocytes and histoincom- 
patible cells when transferred to  appropriate hosts.  Recently, it was  demonstrated 
that for 1-2 days after the injection of such antigens in mice (3) or rats (4, 5),  there 
was a specific deficiency in thoracic duct lymph of cells able to mount adoptive im- 
mune responses to these antigens. The results were  interpreted in terms of antigen- 
induced selective recruitment of specific  lymphocytes from  the recirculating pool to 
appropriate lymphoid organs. As a corollary, it would be expected that at this time 
such organs, e.g. the spleen,  would be enriched in cells specific for these antigens. 
The present experiments were  designed to  test  this corollary. They led  to 
the unexpected and paradoxical observation that the reactivity of cells taken 
from lymphoid organs of mice given antigen 1-2 days previously was markedly 
and specifically depressed  when  tested  in an adoptive  transfer system under 
strict experimental conditions. 
Materials and Methods 
Animals.--In  the experiments, the results of which are presented in Tables I-III and V 
and in Figs. 2-4 (performed at the Waiter and Eliza Hall Institute), highly inbred CBA/H 
mice (obtained originally from Harwell, Didcot, Berkshire, England) were used. In the ex- 
periments, the results of which are presented in Tables IV and VI-IX and in Fig. 1 (per- 
formed at the Basel Institute for Immunology), a shortage of inbred strains necessitated the 
use of F1 crosses between CBA/J and C57BL/6 (the inbred strains being obtained originally 
from Jackson Laboratory,  Bar Harbor,  Maine).  All mice were given Barastoc  cubes and 
water ad llbltum. 
Cell Suspensions.--Thymus,  spleen, bone marrow, mesenteric lymph nodes, and Peyer's 
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patches were obtained from male and female mice aged ~I0 wk old.  With the exception of 
bone marrow, ceil suspensions were prepared by teasing the organs with fine forceps through 
an 80 mesh stainless steel sieve in cold Eisen's solution (6). Marrow cells were expressed from 
the femurs and tibiae by means of a syringe and needle using cold Eisen's solution. The mar- 
row plugs were gently disrupted through a 26 gauge needle by aspiration. All cell suspensions 
were centrifuged once and resuspended in Eisen's solution except thymus cells, which were 
washed twice before resuspension. Counts of viable ceils were performed using the trypan 
blue  exclusion  technique  (7),  the unstained cells  being counted in  a  hemacytometer. The 
volume was then adjusted so that the cells could be injected in a volume of 0.2-0.8 ml. 
Erythrocytes were obtained from the jugular  veins of sheep  (SRC) 1 and horses (HRC) 
and stored in Alsever's solution. When required they were washed three times in saline and 
resuspended to  an appropriate volume. In general,  109  erythrocytes were contained in 0.2 
ml of a  25% suspension and 5  X  108 cells in 0.I  ml of a  25% suspension. The number of 
erythrecytes injected varied in different experiments and are shown in the tables. 
Injections.--All  suspensions of  lymphoid cells  and  heterologous erythrocytes were  in- 
jected intravenously via the lateral tail vein. Unless otherwise indicated, lymphoid cells were 
administered within 6 h of the recipients being irradiated. 
Irradiation.--Mice  were exposed to  total  body irradiation in  a  Perspex box.  The  dose 
given was 750 R to midpoint with maximum backscatter conditions and the machine operated 
under conditions of 250 k¥, 15 mA, and a half-value layer of 1 mm of Cu. The focal skin dis- 
tance was 50 cm and the absorbed dose rate 170 R per min. All irradiated mice received poly- 
myxin B  (100,000 IU/liter) and neomycin (10 mg/liter) in the drinking water. 
Thymeclomy.--Mice were thymectomized at 6 wk of age according to the technique out- 
lined by Miller (8). Thymectomized mice were irradiated 3 wk after the operation. 
Plaque-Forming Cell (PFC) Assays.--Spleen  cell suspensions were prepared as mentioned 
above, washed once,  and diluted to an appropriate volume in Eisen's solution so that 0.1 ml 
contained an estimated 100-1,000  PFC. Direct (19S) PFC were estimated by the method of 
Cunningham and Szenberg (9). Indirect (7S) PFC were determined by adding a rabbit anti- 
mouse immunoglobulin serum to the reactive mixture (10, 11). The number of 7S PFC was 
derived, by difference, from numbers obtained in assays performed in the presence or absence 
of this antiglobulln reagent. 
Rosette-Forming Cell (RFC) Assays.--Spleen  cell  suspensions and  heterologous erythro- 
cytes were mixed, centrifuged, and gently resuspended according to  the method of Wilson 
(12). Only lymphocytes surrounded by a complete halo of erythrocytes were scored as rosettes. 
In order to estimate the number of RFC in a  given suspension, spleen cells were screened 
using hemacytometers until 20-40 rosettes had been counted. This involved screening 5-15 X 
104 spleen cells. 
Hemagglutlnfn assays were performed by the method of Dietrich (13). 
Antlsera.--Anti-O-C3H serum was prepared by giving 107 CBA/J thymus cells once weekly 
to AKR mice as described by Reif and Allen  (14). The mice were bled 7-10 days after the 
last of 9-10 injections. Serum from (CBA/J X  C57BL/6)F1 mice was used as normal mouse 
serum  (NMS).  All  sera were inactivated at  56°C for 30  rain before use.  Fresh guinea pig 
serum was used as a source of complement in experiments in which antisera were used to kill 
appropriate target cells. 
Statistical Analyses.--Geometric mean and standard errors (SE)  of the means were calcu- 
lated from the logl0 of the PFC counts. Arithmetic means and SE of the means were calcu- 
lated from the reciprocal of the log~ values for the hemagglutinin titers. P  values were deter- 
1 Abbreviations used in this paper: HRC,  horse erythrocytes; NMS, normal mouse serum; 
NS,  not significant; PFC,  plaque-forming cells;  19S  PFC,  direct plaque-forming cells;  7S 
PFC,  indirect  (developed)  plaque-forming cells;  RFC,  rosette-forming cells;  SRC,  sheep 
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mined by Student's t  test. In the comparison of the means of any two groups of observations, 
a  significance level of 0.05 was chosen. 
RESULTS 
Specific  Unresponsiveness of Lymphocytes  Transferred  24  h  after In  Vivo 
Exposure  to Heterologous Erythrocytes.--The  adoptive response of spleen cells 
from normal mice given antigen 24 h  before, i.e.  "primed" for 24 h, was in- 
vestigated  as  follows:  normal  mice  were  injected  intravenously either with 
109 SRC,  109 HRC, or left uninjected. 24 h  later, 3  X  107 viable spleen cells 
were given intravenously together with 5  X  l0  s SRC  and 5  N  l0  s HRC  to 
irradiated mice,  and splenic PFC  were measured  at  7 days.  Whereas spleen 
cells from unprimed mice (group 1, Table I) responded well to both SRC and 
HRC,  cells from donors primed  to SRC  1 day before transfer  (group 2)  re- 
sponded well to HRC but poorly to SRC. Likewise, cells from donors primed 
to HRC  1 day previously responded well to SRC but not to HRC  (group 3). 
Results similar to those shown in Table I  were obtained in more than 20 
other experiments. In only two of these did the administration of one antigen 
to spleen cell donors 24 h  before transfer fail to reduce the adoptive immune 
7S PFC response to this antigen by more than 30-fold, as compared with the 
response obtained to this same antigen with spleen cells from donors primed 
to another antigen. The reduction in the 19S PFC response varied considerably 
in different experiments but it was usually more than 10-fold. Unresponsiveness 
was highly specific in that the response to the antigen to which the spleen cell 
donors had  not  been  primed  was  usually not  significantly lower  than  that 
TABLE  I 
PFC in  Spleens of Irradiated Mice Injected 7 Days before with SRC,*  HRC,*  ~nd Spleen 
Cdls~ from Mice Primed for 24 h with SRC or HRC§ 
Antigen given to 
donors  of spleen  Group 
cells 24 h before  no. 
transfer 
PFC per spleen at 7 days 
AntI-SRC  Anti-HRC 
19S  7S  19S  7S 
None  1  3,350*'  62,580  1,920  15,030 
(3,920-2,860)  (73,850-53,040)  (2,450-1,500)  (17,290-13,070) 
SRC]]  2  240  1,020  1,260  13,540 
(350-170)  (1,300-790)  (1,610-980)  (16,790 10,920) 
HRCJ]  3  2,190  48,560  60  20 
(3,070-1,570)  (65,560-35,970)  (70-50)  (90-6) 
P values between groups--19S  PFC to SRC: 1 of. 2, <0.0005; 1 cf. 3, NS; 2 cf, 3, <0.005.  7S PFC to SRC: 
lef. 2,<0.0005;lcf. 3, NS;2cf. 3,<0.0005.  19SPFCtoHRC:lcf. 2, NS;lcf. 3,  <0.0005;2cf. 3,<0.0005. 
7S PFC to HRC: 1 of. 2, NS; 1 cf. 3, <0.0005; 2 el. 3, <0.0005. 
* 0.1 of ml 25% suspension  of erythrocytes (5 X 10  s) given intravenously. 
3 X  107 viable cells injected intravenously. 
Spleen cells and antigen were given within 6 h of irradiating the recipients; results similar to those shown 
here were obtained when the recipients were irradiated 3 days before transfer. 
I[ 0.2 ml of 25% suspension  of erythrocytes (109) given intravenously. 
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obtained by transferring unprimed spleen cells. Only in a few experiments was a 
two to threefold decrease observed as exemplified in Table II. 
The specific unresponsiveness of lymphoid cells adoptively transferred from 
donors primed 1 day before was not restricted to spleen cells but was also ob- 
served with  cells  from mesenteric  lymph  nodes  and  Peyer's patches  (Table 
"FABLE II 
PFC in  Spleens  of Irradiated Mice Injected with  Lymphoid  Cells from  Donors Primed  24  h 
Previously with SRC* or HRC* 
Cells injected  6  NO.of 
together with  ~"  mice 
SRC~; and HRC;  2  per 
:~  group 
PFC per spleen at 7 days 
Anti-SRC  Anti-HRC 
19S  7S  19S  7S 
3 X  10  7 unprimed 
spleen~ 
2 X  10 7 unprimed 
lymph node 
10 7 unprimed 
Peyer's patch 
3 X  1o  7 SRC- 
primed spleen 
2 X  107 SRC- 
primed lymph 
node 
107 SRC- primed 
Peyer's patch 
3 X  10 r HRC- 
primed spleen 
2 X  10 7 HRC- 
primed lymph 
node 
10  7 HRC-primed 
Peyer's patch 
1  3  24,59011  329,750  24,990  181,150 
(28,030-21,570)  (392,400-277,100)  (29,490-21,180)  (222,800-147,280) 
2  4  13,160  106,360  5,980  53,830 
(16,850-10,280)  (126,570-89,380)  (6,580-5,440)  (87,500-54,200) 
3  3  8,190  42,450  2,690  12,330 
(5,970-4,510)  (61,128-29,480)  (3,77%1,920)  (14,800-10,280) 
4  6  1,890  590  7,130  48,820 
(2, 280-1,560)  (2,110-160)  (9,260-5,280)  ((53,700-44.380) 
5  5  330  240  6,750  43,560 
(370-290)  (1,190-50)  8,170-5,580)  (56,650-44,  510) 
6  3  8  30  2,210  6,270 
(50-2)  (136-8)  (4,460--1,090)  (12,340-3,180) 
7  5  12,610  105,310  1,170  410 
(15,38[~10,340)  (130,580-84,930)  (1,400-980)  (650-280) 
8  5  12,930  100,830  530  410 
(16,030-10,430)  (115,930-87,680)  (690-40)  (770-220) 
9  4  1,450  16,940  60  9 
(1,605-1,240)  (20,330-14,120)  (100-60)  (30-2) 
P  values between groups--19S PFC to SRC: 1 cf. 4, <0.0003; 1 cf. 7, <0.025; 4 of.  7,  <0.0005; 2 cf. 5,  <0.0005; 
2 cf. 8, NS; 5 cf. 8, <0.0005; 3 cf. 6, <0.005; 3 cf. 9, <0.005; 6 cf. 9,  <0.005.  7S PFC to SRC:  1 cf. 4,  <0.005; 
1 cf, 7,  <0.005; 4 cf. 7,  <0.005; 2 cf. 5,  <0.01;  2 cf. 8, NS; 5 cf. 8, <0.005; 3 el. 6,  <0.005; 3 cf. 9,  <0.05; 6  ef. 9, 
<0.005.  19S PFC  to HRC:  1 cf. 4,  <0.005;  1 cf. 7,  <0.0005;  4 cf. 7,  <0.0005;  2 cf. 5, NS; 2 cf. 8,  <0.0005; 
5 cf. 8, <0.0005; 3 el. 6, NS; 3 cf. 9, <0.005; 6 cf. 9,  <0.005.  7S PFC to HRC: 1 cf. 4, <0.0005; 1 cf. 7,  <0.0005, 
4 of. 7,  <0.0005; 2 cf. 8, NS; 2 el. 8,  <0.0005; 5 of. 8,  <0.0005; 3 cf. 6, <0.005; 3 cf. 9,  <0.005; 6 of. 9,  <0.01. 
* 0.2 ml of 25% suspension of erythrncytes (109) given intravenously. 
+. 0.1 ml of 28% suspension of erythrocytes (5 X  l0  s) given intravenously. 
§ Number of viable cells given intravenously. 
I[ Geometric mean, upper and lower limits of SE. 
II). Here, as in the preceding experiments, the PFC responses were measured 
7 days after cell transfer. 
The hemagglutinin titers in serum of irradiated mice, obtained 7 days after 
cell transfer, were markedly and specifically reduced when the cell donors had 
received antigen 24 h before transfer (Table III). This excluded the possibility 
that  the  transferred  spleen  cells  might  have  produced  antibody  in  regions 
other than the spleen. 
In  the  above  experiments,  specific  unresponsiveness  of  cells  exposed  to 
antigen for 24 h was revealed upon adoptive transfer. Would such unresponsive- J.  SPRENT  AND  J.  F.  A.  t'.  MILLER  147 
ness  have  occurred  had  the  cells  not  been  transferred?  To  determine  this, 
normal mice received two doses of antigen  24 h  apart; either 109 SRC  or 109 
HRC  were given  intravenously,  and  1  day later  both  groups  of mice  and  a 
third group that had not been given erythrocytes were injected intravenously 
with 5  X  10 s SRC and 5  X  108 HRC.  PFC in the spleens of these mice were 
measured 7  days later.  As seen in Table IV,  injecting two doses of the same 
antigen 24 h apart had no effect on the 19S and 7S PFC response to that antigen 
but produced a three to fivefold decrease in the response to the other antigen, 
probably as a  result of antigenic competition  (15). 
Specific  unresponsiveness  after  adoptive  transfer  was  also  demonstrable 
with cells from mice primed to antigen 1 mo previously. However this occurred 
only  if  these  mice  received  the  same  antigen  24  h  before  their  spleen  cells 
TABLE  III 
Hemagglutinln  Titers of Serum Obtained from Irradiated  Mice 7 Days after Injection of SRC,* 
HRC,* and Spleen  Cdls~ from Mice Primed with SRC§ or HRC§ 24 h Previously 
Antigen given to  1/log2 Hemagglutinin titers 
donors of spleen 
cells 24 h  AntI-SRC  P  value  Anti-HRC  P  value  before transfer 
SRC  1.1H  -4-  0.1 )  5.84-0.3) 
< 0. 0005  < 0. 0005 
HRC  7.0  4-  0.4  1.1  -4-  0.1 
* 0.1  ml of 25% suspension of erythrocytes  (5)<  108) given intravenously. 
:~ 3  X  107 viable ceils given intravenously. 
§ 0.2 ml of 25% suspension of erythrocytes (109) given intravenously. 
[I Arithmetic mean 4- SE, six mice per group. 
TABLE  IV 
PFC in Spleens  of Normal Mice Primed with Either SRC or HRC and  Challenged 24 h Later 
with Both SRC and HRC 
Antigen injected at 
Day 0*  Day 1~ 
PFC per spleen at day 8 
Anti-SRC  Anti-HRC 
19S  7S  19S  7S 
None  SRC +  HRC  1  3,840§  54,030  4,730  31,190 
(5,720°2,580)  (70,240-41,560)  (5,770--3,870)  (37,120026,210) 
SRC  SRC +  HRC  2  1,550  51,410  1,930  9,530 
(2,19001,100)  (59,630-44,320)  (3°11001,200)  (12,10007,500) 
HRC  SRC +  tIRC  3  940  12,040  4,220  53,500 
(1,190-740)  (14,330010,120)  (5,060-3,510)  (69,550-41,160) 
P  values between groups--19S PFC to SRC: I cf. 2, NS; 1 cf. 3, <0.01; 2 cf. 3, NS.  7S PFC to SRC: 1 cf. 2, 
NS;  i  cf.  3,  <(0.0005; 2  cf.  3,  <(0.0005.  19S  PFC  to HRC: 1 cf. 2,  <0.05;  1 cf.  3,  NS;  2  cf.  3  NS.  7S 
PFC to HRC: 1 cf. 2, <0.005; 1 cf. 3, NS; 2 cf. 3, <0.0005. 
* Antigen given as 0.2 ml of 25% suspension of erythroeytes (109) intravenously. 
:~ Antigen given as 0.1 ml of 25% suspension of erythrocytes (5 X 108) intravenously. 
§ Geometric mean, upper and lower limits of SE, six mice per group. 148  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
were  transferred.  The  results  of  such  an  experiment  are  shown in  Table  V. 
Groups of normal mice were injected intravenously with SRC  or HRC.  1 mo 
later half the mice in each group were given the same antigen.  24 h  later,  107 
spleen cells from mice of each of the four groups were transferred to irradiated 
recipients together with both SRC and HRC and numbers of PFC measured at 
7  days.  Challenge  of the cells  with  the priming  antigen  24  h  before  transfer 
produced  a  five to sixfold  reduction in both the  19S  and  7S  response  to this 
TABLE  V 
PFC in Spleens  of Irradiated Mice Injected  with Spleen  Cdls* from Donors Primed u~th SRC 
or HRC 1 mo Previously.  Effect of Injecting Donors with a Second Dose of Antigen 
24 h Before Adoptive  Transfer 
Antigen given 
to spleen cell 
donors before 
adoptive transfer 
30 days  1 day 
before  before 
trans- 
transfers  fer§ 
SRC  none 
SRC  SRC 
HRC  none 
HRC  HRC 
Antigen injected 
together with 
transferred spleen 
cells~ 
SRC +  HRC 
SRC +  HRC 
SRC +  HRC 
SRC +  HRC 
PFC per spleen  at 7 days 
Anti-SRC  Anti-HRC 
19S  7S 
14,81oi] 
(19,690-11,130) 
2,600 
(2,780-2,430) 
2,910 
(3,320-2,560) 
4,500 
(5,580-3,630) 
119,330 
(126,490-112,580) 
21,980 
(23,950--20,160) 
24,860 
(29,580-20,890) 
33,620 
(42,690-26,470) 
19S  7S 
1,350  10,070 
(1,650-1,100)  (16,010-6,330) 
1,050  5,450 
(1,220-910)  (6,260-4. 740) 
21,390  65,990 
(23,960-19,100)  (75,890-57,380) 
660  11,540 
(1,050-410)  (13,610-9,780) 
P values between groups--19$ PFC to SRC: 1 ef. 2, <0.0005; 3 cf. 4, NS.  7S PFC to SRC: 1 el. 2,  <0.0005; 
3 ef. 4, NS.  19S PFC toIlRC: 1 cf. 2, NS; 3 cf,4, <0.0005.  7S PFC to HRC: 1 cf. 2, NS; 3 cf. 4,  <0.0005. 
* 107 viable cells given intravenously. 
0.I ml of 25% suspension of erythrocytes (5 M l0 s) given intravenously. 
§ 0.2 ml of 25% suspension of erythrocytes (109) given intravenously. 
]] Geometric mean, upper and lower limits of SE, six mice per group. 
antigen, except in the case of the 19S response to HRC where a 30-fold decrease 
occurred. 
Certain  parameters  were  common  to  the  experiments  described  above: 
(a)  a dose of 109 erythrocytes was used to prime the cell donors; (b) ceils were 
transferred 24 h after priming; (c) irradiated recipients of cells were challenged 
with antigen immediately upon transfer; (d)  the PFC responses were measured 
7 days after cell transfer. The effects of varying each of these four parameters 
individually will now be considered. 
Dose of priming antigen: Only high  doses  of the priming  antigen  rendered 
lymphoid cells unresponsive upon adoptive  transfer. Thus  intravenous injec- 
tions of from 1@ to  107 SRC  to donors 24 h  before cell transfer produced no 
decrease in either the 19S (Fig. 1 a) or 7S (Fig. 1 b) response to SRC. A marked 
decrease  was  observed  with  higher  doses  of  antigen  and  with  109-101°  SRC j.  SPRENT  AND  J.  F.  A.  P.  MILLER  149 
5 
Z 
I.O 
W 
09 
w  4 
U3 
O 
I1. 
0_ 
83 
a 
t\t. 
--II  , 
4  ,~  ~  ÷  & 
LOG 
b 
/t 
1'o  o  4  g  ~  ~  &  6  1'o 
DOSE  OF  ANTIGEN 
Fro. 1.  Numbers of  19S  (group a) and 7S  (group b) PFC in spleens of irradiated mice 7 
days after intravenous injection of 5 X  10 s SRC and 5 X  108 HRC given together with 3 X 
107 viable spleen cells from mice primed 24 h  previously with varying numbers of SRC in- 
jected intravenously.  •  =  anfi-SRC PFC;  O  =  anti-HRC PFC.  Geometric means of the 
results obtained from five mice are given, and vertical bars represent upper and lower limits 
of SE. 
the response to SRC was virtually abolished. Such doses of SRC produced no 
reduction in the responses to HRC. 
Interval between priming and adoptive transfer:  Normal  mice  were  injected 
with SRC or HRC and then killed immediately or 1, 2, 3, or 5 days later. Spleen 
cells from each group were injected into irradiated mice, together with SRC and 
HRC, and PFC responses were measured 7 days after transfer. Responses ob- 
tained with spleen cells transferred immediately after the donors had received 
one of the  two antigens  were similar to  those  occurring in  recipients of ceils 
from donors not given this antigen (Fig. 2). By contrast, and as already shown 
in experiments described above, a delay of 1 day between antigen priming and 
cell  transfer resulted in  a  marked and  specific reduction  of both  19S  and  7S 
PFC responses to the antigen used for priming. This reduction was much less 
when the cells were transferred 2 days after antigen priming and was not de- 
tectable at 3  or 5  days postpriming. A  reduction was observed after 2  days' 
priming in  the  19S  PFC  response of the  transferred  cells to the  antigen  not 
used for the priming. The 7S PFC responses here were not reduced. 
Interval  between adoptive lransfer  and  antigen  challenge: Spleen  cells  from 
normal mice injected with SRC  or HRC 24 h  previously were transferred  to 
irradiated  mice  that  were  then  challenged  with  both  SRC  and  HRC  either 
immediately or 1, 5, 9, or 16 days later. PFC responses in mice of each group 
were determined 7 days after antigen challenge. In order to exclude the possi- 1.~0  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
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FIG. 2.  Numbers of 19S PFC  to SRC  (group a) and to HRC  (group b) and of 7S PFC to 
SRC  (group c)  and to HRC  (group d) in spleens of irradiated mice 7 days after intravenous 
injection of 5 X  l0 s SRC and 5 X  l0 s HRC given together with 3 X  107 viable spleen cells 
from mice injected intravenously at various times before transfer with 109 SRC  (O) or 10 ~ 
HRC  (O).  Geometric means of the results obtained from six mice are given, and the vertical 
bars represent the upper and lower limits of SE. P values between groups--(a) : day 1, <0.0005; 
day 2,  <0.005; day 3,  <0.005; (b) : day 1,  <0.005; dav 2, NS; day 3, NS; (c) : day 1, <0.0005; 
day 2,  <0.0005; day 3, NS; (d): day 1,  <0.0005; day 2,  <0.0005; day 3, NS. 
bility that hemopoietic stem cells present in the spleen cell  suspensions might 
differentiate to T  cells in the irradiated host and thus  obscure the response of 
the  transferred  spleen  cells  per  se,  all  recipients  were  thymectomized 3  wk 
before irradiation. A marked specific reduction in PFC responses was observed 
when  the  challenge  antigen  was  given  together  with  the  transferred  spleen 
cells or 1 day later (Fig. 3). This applied to both the 19S and 7S PFC responses 
except in the case of the 19S PFC response to HRC (Fig. 3 b) where a delay of 
1  day in  the  administration  of the  challenge  antigen  was  associated  with  a 
response similar to that obtained with cells from donors not primed to HRC. 
Striking  differences were  observed when  challenge  with  antigen  was delayed J.  SPRENT  AND  .]'. iF.  A.  P.  MILLER  151 
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FIG. 3.  Numbers of 19S PFC to SRC (group a) and to HRC (group b) and of 7S PFC to 
SRC  (group c) and to HRC  (group d) in spleens of irradiated mice 7 days after intravenous 
injection of 5 X  l0 s SRC and 5  X  l0 s HRC  given either together with--or 1, 5, 9, or 16 
days after--an inoculum of 3 X  107 viable spleen cells from donor mice primed 24 h previ- 
ously with 109 SRC  (e)  or 109 HRC  (O)  intravenously. Geometric  means  of the  results 
obtained from six mice are given,  and vertical bars represent upper and lower limits of SE. 
P  values between groups--(a) : day 1, <0.0005; day 5, NS; day 9,  <0.025; (b) : day 0,  <0.05; 
day I, NS; day 5,  <0.0005; day 9,  <0.01; (c): day 1,  <0.0005; d~y 5,  <0.01; day 9, NS; 
(d): day 1,  <0.0005; day 5,  <0.0005; day 9,  <0.01. 
for 5  days. Thus, in the case of the 7S PFC response to SRC,  the numbers of 
PFC  given  by SRC-primed  spleen cells significantly exceeded  those given  by 
HRC-primed  spleen  cells  (Fig.  3 c).  Similar  changes  were  noted  with  both 
the  19S  and  7S  PFC  responses  to HRC  (Fig.  3 b  and d),  akhough  the  19S 
PFC response to SRC  was similar whether or not the spleen cells were taken 
from donors primed to this antigen  (Fig.  3 a). It is clear from Fig.  3  that in- 
creasing the time interval between cell  transfer and antigen challenge from 1 152  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
to 5 days was associated not only with an increase in the response of the primed 
cells to the priming antigen but also with a concomitant decrease in the response 
to this antigen by cells primed to the other antigen. Essentially similar changes 
were observed when antigen challenge was delayed for 9 or 16 days. 
Interval  between antigen  challenge and  PFC assays:  In  order  to  determine 
whether responses occurred at times other than 7 days after cell transfer and 
antigen challenge, splenic  PFC  were measured in irradiated mice at 5,  7,  8, 
and 11  days after transfer of SRC-primed or HRC-primed spleen cells given 
together with both SRC  and HRC. Whereas a  reduction in both 19S and 7S 
PFC responses to the priming antigen was evident at 5 and 7 days, it was less 
apparent at 8 days, and only very slight at 11 days (Fig. 4). In the case of the 
19S PFC responses, these changes can largely be accounted for by a decline in 
the PFC responses of the respective control groups after 7 days. With the 7S 
responses, however, a clear increase was observed between 7 and 11 days and 
associated with only a slight decrease in the responses of the controls. 
Specific  Unresponsiveness in  Both  T  and  B  Lymphocytes.--Since  the  PFC 
response of mice to sheep erythrocytes requires collaboration between thymus- 
derived (T)  and non-thymus-derived (B) cells  (16,  17),  it was  of interest to 
determine whether the specific unresponsiveness of recently primed cells ob- 
served on adoptive transfer was  due  to  a  defect occurring in  either T  cells, 
B cells, or in both types of cells. This was investigated by determining whether 
the unresponsiveness could be reversed by adding either normal T  or normal 
B cells. The experimental design was the same as that used to obtain the results 
shown in Table I. Thus spleen cells primed to SRC or HRC 24 h before were 
transferred either with SRC and HRC alone or together with 10  s thymus cells 
or 2 X  107 bone marrow cells; thymus and bone marrow were used as sources 
of T  and B cells, respectively (17). As shown in Table VI, the addition of bone 
marrow to SRC- or HRC-primed spleen cells did not overcome the unrespon- 
siveness of the cells to the priming antigen  (groups 3 and 6); this applied to 
both the  19S  and  7S PFC response. Thymus cells, by contrast, did produce 
partial reconstitution of the response  (groups 4  and  7),  particularly the  19S 
response. That thymus and bone marrow were suitable as sources of T  and B 
cells in these experiments was shown by their capacity to respond to the anti- 
gens  when  injected  together  (group  10)  but  not  when  injected  separately 
(groups 8 and 9). 
The failure of thymus cells to effect full reconstitution of the response of 
the antigen-primed spleen cells might have been due to one of the following: 
(a) suboptimal  numbers  of  competent  T  cells  in  the  suspensions  used;  (b) 
existence of suppressor T  cells (18); (c) specific unresponsiveness affecting the 
B cell population of the primed spleen. 
In order to investigate these possibilities,  spleen cells from normal mice or 
from mice primed 24 h before with SRC or HRC were incubated in vitro with 
anti-0-serum and complement (see  footnote to Table VII)  so as to eliminate j.  SPRENT  AND  J.  ~. A.  P. MILLER  153 
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FIG. 4.  Numbers of 19S PFC to SRC  (group a) and to HRC (group b) and of 7S PFC to 
SRC  (group c) and to HRC  (group d) in spleens of irradiated mice at various times  after 
intravenous injection of 5 X  l0 s SRC and 5 X  l0 s HRC given together with 3 X  107  viable 
spleen cells from donor mice primed 24 h previously with 109 SRC  (@) or 109 HRC  (O) in- 
travenously. Geometric means of the results obtained from six mice are given,  and vertical 
bars represent upper and lower limits of SE. P  values between groups--(a): day 7,  <0.0005; 
day 8, NS; day 11, NS; (b): day 7,  <0.0005;  day 8, NS; day 11, NS; (c): day 7,  <0.0005; 
day 8,  <0.0005;  day 11,  <0.025;  (d): day 7,  <0.0005;  day 8,  <0.0005; day 11,  <0.01. 
T  cells. The effect of adding l0  s normal thymus cells to such spleen cell suspen- 
sions was then investigated by adoptive transfer. PFC responses in irradiated 
recipients  were  measured  at  7  days  and  compared  with  responses  given  in 
recipients of primed spleen cells treated in vitro with NMS  and complement 
before  transfer.  The  results  are  shown  in  Table  VII.  It  is clear that  anti-0- 154  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
TABLE  VI 
PFC in  Spleens  of Irradiated  Mice Injected  with Spleen  Cdls*  from  Donors  Primed  24  h 
Pra,iously with SRC~ or HRC.~ Effect of Injecting Normal  Bone Marrow or Thymus Cells 
PFC per spleen at 7 days 
Cells  injected together  ~  Anti-SRC  Anti-HRC 
with SRC§ and HRC§  ~e 
©  198  7S  19S  7S 
Unprimed  spleen  1  14,470H  159,560  9,940  133,570 
(23,000-9,100)  (197,850`128,680)  (11,930-3,280)  (157,620-113,200) 
SRC-primed spleen  2  570  c)00  13,050  172,300 
(780-410)  (3,6S0-220)  (19,190-8,880)  (225,830-131,590) 
SRC-primed spleen +  3  150  100  7,360  129,120 
2 X  107 bone marrow  (240-90)  (630-10)  (11,040,4,910)  (166,560-100,090) 
SRC-primed spleen +  4  3,780  8,000  27,740  326,880 
108 thymus  (4,840-2,950)  (10,000-6,400)  (36,620-21,020)  (,151,090-234,870) 
tlRC-primed spleen  5  19,840  287,660  1,300  600 
(27,780-14,170)  (370,310,222,530)  (1,670-1,010)  (2,590  180) 
HRC-primed bpleen +  6  22,190  109,080  460  300 
2 X  1!)  7 bone marrow  (29,520-16,690  (135,160-87,970)  (660-3.30)  (I,170,70) 
ttRC  primed  spleen +  7  38,560  304,980  8,430  6,890 
108 thymus  (57,850-25,710)  (338,530-274,750)  (14,080-5,050)  (7,370,6,440) 
2 X  10 7 bone marrow  8  0  3  0  9 
(10-1)  (30-3) 
108 thymus  9  20  10  7  0 
(110-5)  (160`1)  (20`3) 
2 X  107 boi,.e marrow Jr-  10  1,380  5,520  1,110  6,180 
108 thymus  (1,930-980)  (6,620-4,600)  (1,500`820)  (8,030-4,750) 
_P values between groups--19S PFC to SRC: 1 c[. 2, <0.0005; 2 cf. 3,  <0.05; 2 cf. 4,  <0.0005; 2 cf. 5,  <0.00(15; 
4 cf. 5,  <0.01.  7S PFC to SRC: 1 cf. 2,  <0.005; 2 cf. 3, NS;  2 cf. 4,  <0.05; 2 of. 5,  <0.0005; 4 ef. 5,  <0.005. 
19S PFC to HRC: 1 cf. 5, <0.02; 5 cf. 6, <0.02; 5 cf. 7, <0.005;  1 cf. 7, NS; 2 cf. 5,  <0.01.  7S PFC to HRC: 
1 cf. 5, <0.00051  5 of. 6, NS; 5 cf. 7, <0.051 1 c[. 7, <0.0005; 2 of- 5, <0.0005. 
* 3  X  107 viable cells given intravenously. 
~+ 0.2 ml of 25% suspension of erythrocytes (109) given intravenously. 
§ 0.1 ml of 25% suspension of erythrocytes (5 X  108) given intravenously. 
I] Geometric mean, upper and lower limits o( SE, five to six mice per group. 
serum treatment of normal spleen ceils caused a marked reduction in both 19S 
and 7S PFC responses to SRC and HRC after transfer and that this reduction 
was largely prevented by supplementing with thymus cells. Likewise, the effect 
of pretreatment with anti-0-serum in abolishing the response of antigen-primed 
spleen cells to the antigen not used for priming was not evident when thymus 
cells  were  also  given.  These  results  imply  that  the  thymus  cell  suspensions 
used contained sufficient numbers of competent T cells to allow normal adoptive 
responses.  When thymus cells were  added  to antigen-primed spleen cells pre- 
treated  with  anti-0-serum,  PFC  responses  to  the  priming  antigen,  however, 
were  only  slightly,  though  still  significantly,  above  those  given  by  NMS- 
incubated primed cells. 
The results obtained above thus suggested that defects in both T  and B cells 
contributed to the failure of recently primed spleen cells to respond on adoptive 
transfer to the priming antigen. There was no evidence that T cells in the trans- 
ferred spleens were suppressing the response. Hence complete restoration should 
occur by supplementing the spleen cells with a mixture containing both T  and J.  SPRENT  AND  J.  F.  A.  P.  MILLER  155 
TABLE  VII 
PFC in  Spleens  of  Irradiated  Mice  Injected  u~th Anti-O-Serum-Treated  Spleen  Cells from 
Unprimed  Mice or from Mice Primed 24 h Previously  with SRC* or HRC.* Partial 
Restoration  of the Immune Response  by  Injection  of Normal  Thymus  Cells 
Serum 
used for 
Cells injected  incubation§  of 
together with  spleen 
cells in 
SRC:~ and HRC:~  vitro in 
presence of  o 
complement 
PFC per spleen at 7 days 
Anti-SRC  Anti-HRC 
19S  7S  19S  7S 
Unprimed spleen  NMS  1  8,620!t  107,440  3,060  90,220 
(10,610-7,010)  (136,440-84,600)  (3,360-2,780)  (101,050-80,560) 
Unprimed spleen  Antl-0  2  320  2,400  10  200 
(600-170)  (3,740-1,540)  (30-4)  (370-100) 
Unprimed spleen  Anti-0  3  3,180  41,140  2,760  50,520 
~- 108 thymus  (3,590-2,810)  (56,370-30,030)  (3,420-2,220)  (59,100-43,180) 
SRC-primed  NMS  4  150  200  1,570  34,710 
spleen  (250-90)  (780-50)  (1,816-1,370)  (47,890  25,150) 
SRC-primed  Anti-0  5  40  20  20  240 
spleen  (50-30)  (30-7)  (50-5)  (350-160) 
SRC-primed  Anti-0  6  1,430  3,940  1,920  41,420 
spleen ~- 108  (1,730-1,180)  (5,160-3,010)  (2,570-1,430)  (45,500-37,650) 
thymus 
HRC-primed  NMS  7  2,530  51,620  180  30 
spleen  (3,140-2,040)  (57,820-46,090)  (240-130)  (110-10) 
HRC-primed  Anti-0  8  100  1,230  20  8 
spleen  (160-60)  (2,860-530)  (~0-I0)  (30-2) 
HRC-primed  Anti-0  9  5,260  74,710  650  1,530 
spleen -b l0 s  (7,680-3,600)  (100,860-55,340)  (1,100-380)  (1,950-1,190) 
thymus 
108 thymus  --  10  6  10  10  210 
(20-2)  (50-3)  (40-3)  (27 0-160) 
P  values between groups--19S PFC to SRC:  1 cf. 2,  <0.005;  1 cf. 3,  <0.005;  2 cf. 3,  <0.005; 4 cf. 5,  <0.02; 
4 cf. 6, <0.005; 7 cf. 8, <0.0005; 8 el. 9, <0.0005.7 cf. 9, NS.  7S PFC to SRC: 1 cf. 2,  <0.0005; 1 of. 3,  <0.02; 
2 cf. 3,  <0.0005; 4 el. 5, NS; 4 cf. 6,  <0.05; 7 cf. 8,  <0.005; 8 cf. 9,  <0.005;  7 cf. 9, NS.  19S PFC to HRC: 
1 cf. 2,  <0.005;  1 cf. 3, NS; 2 ef. 3,  <0.0005; 4 of. 5,  <0.005; 4cf. 6, NS; 5 cf. 6,  <0.005; 7 cf. 8,  <0.02; 7 cf. 9, 
<0.05.  7S PFC to HRC: 1 cf. 2, <0.0005; 1 cf. 3, <0.01; 2 cf. 3, <0.0005; 4 cf. 5,  <0.0005; 4 cf. 6, NS;  5 cf. 6, 
<0.0005; 7 cf. 8, NS; 7 cf. 9,  <0.005. 
* 0,2 ml of 25% suspension of erythrocytes (109) given intravenously. 
$ 0.1 ml of 25% suspension of erythrocytes (5 X  108) given intravenously. 
§ Spleen cells were incubated at 5 X  107 cells per ml with 1:4 dilution of serum at 37°C for 20 min, washed 
once, and then incubated for 20 rain at 37°C with complement. 2 X  107 cells were then transferred intravenously 
with antigen to irradiated mice. Viability of transferred cells: NMS-treated =  80-90%; anti-0-treated =  45-60%. 
]] Geometric mean, upper and lower limit of SE, five mice per group. 
B  cells.  The experimental results given in Table VIII  substantiate  this pre- 
diction in that addition of normal spleen cells from unprimed mice to spleen 
cells from mice primed 1 day before allowed good adoptive immune responses 
to the antigen used for priming. 
Capacity lo Bind Antigen.--It might be suggested that the specific unrespon- 
siveness of adoptively transferred spleen cells from 1 day-primed mice resulted 
from a  specific inability of the cells to recognize antigen after transfer.  For 
example, contact with antigen before transfer could have led to a  temporary 
loss of antigen-specific receptors. It was thus decided to determine the number 
of cells in spleens of unprimed mice or of mice primed 24 h before to SRC that 156  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
TABLE VIII 
PFC in Spleens of Irradiated Mice Injected with Spleen Cells  from Mice Primed 24 h Previously 
with SRC* or HRC.* Effect of Injection  of Normal Spleen Cells 
Cells*  injected  5 
together with 
SRC§ and HRC§ 
PFC per spleen at 7 days 
Anti-SRC  Anti-HRC 
195  75  195  75 
Unprimed spleen  1  5,420]!  100,370  6,960  61,730 
(7,540  3,900)  (107,400-93,810)  (8,630-5,610)  (82,720-46,070) 
SRC-primed spleen  2  90  190  2,300  27,020 
(110--70)  (330-110)  (2,560-2,080)  (28,820-22,800) 
SRC-primed spleen  3  8,160  177,370  24,620  281,760 
+  unprimed spleen  (10,290-6,480)  (205,750-152,900)  (28,320-21,400)  (335,290-236,770) 
HRC-primed spleen  4  6,000  97,810  410  9 
(7,740-4,650)  (108,570-88,120)  (480-350)  (40-2) 
HRC-primed spleen  5  9,810  115,150  7,250  56,030 
+  unprimed spleen  (11,280-8,530)  (132,420-100,130)  (8,700-6,050)  (67,800--46,300) 
P  values between groups--19S PFC to SRC: 1 cf- 2, <0.005; 1 cf. 3, NS; i  of. 4, NS; 2 cf. 3,  <0.005.  7S 
PFCtoSRC:lef. 2,<O.OO5;lcf. 3,<O.OO5;lef. 4, NS;2cf. 3,<0.0005.  195 PFC to HRC: I cf. 4, <0.0005; 
1 cf.$, NS;  lcf. 2,  <0.01;  4  el.5,  <  0.0005.  75 PFC to HRC: 1 cf.4,  <0.0005;  1 cf. 5, NS;  I  cf. 2,  <0.01; 
4 el. 5, <0.0005. 
* 0.2 ml of 25~ suspension o[ erythrocytes (109) given intravenously. 
:~ 3 X 107 viable cells of each spleen cell suspension given intravenously. 
§ 0.1 ml of 250"/0  suspension of erythrocytes (5 X  10  s) given intravenously. 
B! Geometric mean, upper and lower limits of SE, six mice per group. 
could form rosettes to SRC. In five separate experiments, the number of RFC 
to SRC found in spleens of SRC-primed mice were reduced to 28-48 % of those 
found in spleens of unprimed mice (Table IX). In the one experiment in which 
numbers of cells forming rosettes to HRC were determined, more rosettes were 
found in SRC-primed spleens than in unprimed spleens. 
DISCUSSION 
Spleen, mesenteric  lymph  node, and Peyer's patch cells from  mice recently 
primed with heterologous erythrocytes were markedly  and  specifically un- 
responsive to the priming antigen, but only on adoptive transfer. Unrespon- 
siveness was  reversible  and  the  transferred  cells  recovered their  reactivity 
after about 5 days. There are several reports that primary immunization with 
antigen,  given  in  doses  normally  considered  immunogenic  rather  than  tol- 
erogenic, can suppress  the immune response to the priming antigen provided 
that antigen challenge was given soon afterwards: 
Tao (19)  observed that fragments of lymph nodes from normal rabbits  or 
rabbits primed 3 days before with OX 174 responded well to this antigen when 
cultured in vitro.  Fragments from donors primed  1-2  days previously, how- 
ever, produced only small amounts of antibody in culture. No explanation was 
given for this finding. 
Katz, Paul,  and Benacerraf (20)  reported that in guinea pigs, the effect of 
carrier  preimmunization  in  promoting  secondary  antihapten  antibody  re- 
sponses  to  heterologous hapten-carrier conjugates was  prevented by supple- .1.  SPRENT  AND  J.  F.  A.  P.  MILLER  157 
TABLE IX 
Numbers  of Rosette-Formlng  Cdls  in Spleens  of Mice Injected  with SRC*  24 h  Previously 
No. of experiment 
Antigen given  RFC per 10  ~ cellsJ; 
to donors  of 
spleen cells  to SRC  to HRC 
1  --  212 
SRC  90  (41%)§ 
L 
--  449  -- 
SRC  172  (38%)  -- 
--  556  -- 
SRC  157  (28%)  -- 
--  331  -- 
SRC  156  (47%)  -- 
--  443  467 
SRC  213  (48%)  627  (134%) 
* 0.2 ml of 25% suspension of erythrocytes  (10 "~) given intravenously. 
Numbers of RFC were determined on suspensions pooled from the spleens of two mice. 
Total cell numbers in spleens of mice injected with SRC were 3-15% higher than in controls 
not given antigen. 
§ Compared with donors not given antigen. 
mental  immunization  with  the  carrier  1 day before  administering  the hapten 
conjugated to this carrier.  This effect appeared nonspecific in that it was also 
observed when an unrelated  carrier was used for supplemental  immunization. 
Cells were not transferred  adoptively in these  studies,  and  the  authors inter- 
preted  their observation in terms of a  suppressive influence exerted by T  cells. 
Armstrong and Kraft  (21)  separated mouse spleen  cells on the basis of size 
by velocity sedimentation and tested immune responses to polymerized flagellin. 
They found that the capacity of cells to form antibody in vitro or in vivo in 
the presence of antigen was restricted  to cells with  a  slow sedimentation  rate 
(small  cells)  when  taken  from unprimed  donors  but  mostly  to  fast  moving 
cells  (blasts)  when  taken  from mice primed  to  the  antigen  48  h  before.  The 
competence of cells from mice primed for 24 h  was likewise  restricted  to the 
large  cell  fraction when  tested  in vitro.  Paradoxically,  however,  none of the 
cell fractions from 24-h primed mice produced antibody in vivo. This was con- 
sidered  to reflect "the manner of antigen contact in the irradiated  host." 
The phenomenon reported  in  this paper  is probably analogous to that ob- 
served by Armstrong and  Kraft  (21),  although in their  study,  it was not es- 
tablished whether the unresponsiveness of cells transferred in vivo was specific 
since  the  response  to  other  antigens  was  not  investigated.  Neither  was  it 
shown  whether  the  transferred  cells  regained  their  reactivity.  On  the  other 158  SPECIFIC  UNRESPONSIVENESS  IN  RECENTLY  PRIMED  CELLS 
hand, the effects described in the present studies are unlikely to be related to 
those described by Katz et al.  (20) since, in our studies, unresponsiveness was 
specific,  demonstrable only after adoptive transfer and not the result of a sup- 
pressive influence exerted by T  cells (18). The relationship of our findings to 
those described by Tao (19) is not clear. 
Several possibilities  can  be  invoked  to  explain  the  results  reported  here: 
(a) In preparing single  cell suspensions for adoptive transfer,  certain cells, 
viz those "transformed" as a  result of antigen activation  (21), might be ab- 
normally  sensitive  to  the  trauma  associated  with  making  cell  suspensions; 
clonal expansion of a  few cells  surviving such  trauma might account for the 
gradual return of reactivity. According to this explanation, it would have to 
be assumed that cells should be much more sensitive to trauma when exposed 
to antigen in vivo for 1 day than for 3 or more days  (Fig.  2).  Furthermore, 
one would expect that single-cell  suspensions from 1 day-primed mice should 
be unresponsive in vitro, whereas tissue fragments, where cell damage should 
be minimal,  ought  to  respond.  In  the  experiments of Armstrong  and  Kraft 
(21),  however, cell  suspensions were  responsive in  vitro,  whereas  in  the  ex- 
periments of Tao  (19)  tissue  fragments were not. It would appear  therefore 
that our findings are unlikely to be explained on the basis of a heightened sus- 
ceptibility of blast cells to the trauma of preparing cell suspensions. 
(b)  A  large proportion of blast  cells  from rats  (22)  or mice  (23), injected 
with  antigen 3-5  days before, migrated  to  the  intestines  rather  than  to the 
spleen after intravenous injection.  Such cells might not therefore reach sites 
conducive  to  their  differentiation into  antibody-forming cells.  The  work  of 
Armstrong and Kraft (21), mentioned above, does not support this possibility. 
Thus, although after 24 h priming, their large cell fraction responded well  to 
the priming antigen when cultured in vitro but not when transferred in vivo, 
after 48 h  priming similar fractions of large cells produced high responses not 
only in vitro but also in vivo. 
(c) Lymphocytes bear surface "receptors" sensitive to trypsin and neurami- 
nidase  (24,  25), which control their pattern of migration. As previously men- 
tioned, it has been suggested that lymphocyte migration is altered soon after 
contact  with  antigen  (3).  Possibly  this  results  from  subtle  changes  in  the 
cell surface membrane that induces cells to become localized in areas conducive 
to the production of antibody, e.g., the primary follicles and germinal centers. 
Once  the  cells  reach these areas,  however, membrane changes might become 
sufficiently extensive to prevent them from reentering such  areas if removed 
and  replaced in  the bloodstream. Spleen cell suspensions from mice recently 
injected with  antigen would  thus  be unable  to  mount  an  adoptive immune 
response in vivo until the surface membrane structures of the activated cells 
had reverted to normal. Detailed knowledge of the migration of recently ac- 
tivated lymphocytes and their subsequent fate must be obtained before this 
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(d)  The unresponsiveness observed in the present system might be due to 
transient induction of high zone tolerance. It could be argued, for example, 
that, unlike small lymphocytes, cells recently transformed in response to anti- 
gen are easily tolerized, but that antigen clearance mechanisms in the intact 
animal  normally protect  such  ceils  from exposure  to  antigen in  tolerogenic 
form or concentration. Such a protective mechanism, however, might no longer 
operate during the preparation of single-cell  suspensions shortly after priming 
with high doses of antigen. The activated cells in these suspensions might then 
be freely exposed to antigen capable of tolerizing. It should be noted that it 
is necessary to invoke a greater sensitivity to tolerance induction of activated 
rather than nonactivated cells, since,  in the case of heterologous erythrocytes, 
the high adoptive responses shown by unprimed spleen cells were not suppressed 
by supplemental injection of 1 day-primed spleen cells (Table VIII). A height- 
ened susceptibility of blast cells to tolerance induction would account for the 
findings of Haskill and Marbrook  (26) that cells  transformed in response  to 
SRC in culture differentiated to PFC in vitro only if antigen was not added. 
To test this possibility, we investigated whether washing 1 day-primed spleen 
ceils  (to remove excess antigen) before transfer and withholding antigen chal- 
lenge of the cells would overcome their unresponsiveness. This was observed 
but only in one of four experiments and then only with the 19S PFC response 
(unpublished data of J.  S.  and J.  F.  A.  P.  M.).  Nevertheless,  other results 
have indicated that  1 day-primed spleen cells,  washed and cultured for 4  h 
without  antigen,  partly  regained  their  capacity  to  respond  to  the  priming 
antigen 7 days after transfer in vivo with the antigen. This was not the case, 
however, when the cells were cultured together with the priming antigen be- 
fore transfer. Further experiments along these lines are in progress. 
(e) The  reduced  antigen-binding  capacity  of  1  day-primed  spleen  cells 
(Table IX), also reported for cells exposed to antigen in vitro for 18 h  (26), 
might imply that activated cells express fewer surface receptors. This might 
prevent  the  cells  from  being  restimulated  on  further  exposure  to  antigen. 
The finding of Diener and Paetkau (27)  that the capacity of lymphocytes to 
bind polymerized flagellin was considerably increased after exposure to antigen 
for 6 h in vitro makes it unlikely that antigen activation reduces the density 
of surface receptors. Possibly the reduction in numbers of RFC in the present 
study was  the  result of receptor blockade by soluble antigen released  from 
macrophages. 
The mechanism by which short-term exposure  to  antigen in vivo renders 
lymphocytes specifically unresponsive on transfer is  clearly not understood. 
Since  unresponsiveness involved both  T  and  B  cells  and  both  19S  and  7S 
responses, the defect is clearly a basic one. It may perhaps be of general im- 
portance  since  recent  studies  have  shown  that  alloantigens  may induce  a 
similar phenomenon. Thus spleen cells from mice exposed to alloantigens for 
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upon  reexposure  to  these  antigens  (unpublished  results  of  J.  S.  and 
J. V. A. P. M.). 
Our  findings  challenge  the  concept  that  lymphocytes  are  selectively  re- 
cruited from the  recirculating pool  to  organs  such  as  the  spleen  and  lymph 
nodes after antigen injection (3-5). Thus, it could be argued that cells are not 
withdrawn  from the  circulation but merely become transiently unresponsive 
as a result of a process similar to that occurring in spleen as described in the 
present studies. Investigation of this possibility will be the subject of the next 
paper in this series. 
SUMMARY 
When  spleen,  mesenteric  lymph  node,  or  Peyer's  patch  cells  from  mice 
primed 24 h before with either sheep erythrocytes (SRC) or horse erythrocytes 
(HRC) were transferred together with both SRC and HRC to irradiated mice, 
antibody responses measured 7 days later were very low to the priming antigen 
but  high  to  the  other  antigen.  This was  demonstrated  either by measuring 
numbers  of  antibody-forming cells in  spleen  or  levels  of  hemagglutinins  ill 
serum.  Specific unresponsiveness of the transferred cells was evident in both 
the 19S and 7S responses. It was observed only when strict experimental con- 
ditions were followed: (a) the cell donors had to be primed with not less than 
109 erythrocytes given intravenously;  (b)  the cells had  to be transferred be- 
tween  1 and 2 days after antigen priming;  (c) antibody responses in  the  re- 
cipients were measured within 7 days of cell transfer, i.e., partial recovery was 
evident by 11  days;  (d)  the  transferred cells had  to  be challenged in  the  re- 
cipients within  1 day  after cell  transfer:  when  challenge  was  delayed for 5 
days or longer, responsiveness returned. 
The failure of cells from recently primed donors to respond to the priming 
antigen on adoptive transfer could be overcome by supplementing with normal 
spleen cells,  but not with thymus alone or bone marrow  alone. This implied 
that unresponsiveness  occurred at  the levels of both T  and  B  lymphocytes, 
and was not due to a  suppressive influence exerted by T  cells.  Further work 
is in  progress  to determine the  mechanism of this  transient  state of specific 
unresponsiveness. 
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